Provided by Tiger Trade Technology Pte. Ltd.

BioNTech SE

96.85
-1.4500-1.48%
Post-market: 96.880.0300+0.03%19:30 EDT
Volume:820.11K
Turnover:79.91M
Market Cap:24.33B
PE:-12.46
High:99.49
Open:97.59
Low:96.60
Close:98.30
52wk High:124.00
52wk Low:79.52
Shares:251.20M
Float Shares:109.00M
Volume Ratio:1.09
T/O Rate:0.75%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-7.7726
EPS(LYR):-5.5184
ROE:-9.30%
ROA:-5.41%
PB:1.22
PE(LYR):-17.55

Loading ...

European Equities Traded in the US as American depositary Receipts Rise in Monday Trading

MT Newswires Live
·
Sep 21

BioNTech CEO Uğur Şahin Reports Disposal of USD 6.24 Million in Common Shares

Reuters
·
Sep 19

BioNTech Names KPMG as New Independent Auditor for 2027 Financial Year

TIPRANKS
·
Sep 19

BioNTech Names KPMG as Independent Auditor for Fy2027

Reuters
·
Sep 19

Top Pharvaris Executive Cashes In on Major Insider Stock Sale

TIPRANKS
·
Sep 18

Sector Update: Healthcare

MT Newswires Live
·
Sep 18

Health Canada Authorizes Pfizer-BioNTech XFG-Adapted COVID-19 Vaccine

Reuters
·
Sep 18

Shionogi’s Phase 3 COVID-19 Antiviral Trial Puts SGIOF Back in the Spotlight

TIPRANKS
·
Sep 18

BioNTech CEO Uğur Şahin Sells $4.73 Million in Common Shares

Reuters
·
Sep 17

BioNTech price target raised to $140 from $132 at Berenberg

TIPRANKS
·
Sep 16

Berenberg Bank Reaffirms Their Buy Rating on BioNTech SE (BNTX)

TIPRANKS
·
Sep 16

Jefferies Remains a Buy on BioNTech SE (BNTX)

TIPRANKS
·
Sep 16

European Equities Traded in the US as American Depositary Receipts Decline in Tuesday Trading

MT Newswires Live
·
Sep 15

Analysts Offer Insights on Healthcare Companies: Benitec Biopharma (BNTC), CVS Health (CVS) and BioNTech SE (BNTX)

TIPRANKS
·
Sep 15

BioNTech and OncoC4 Report Survival Gains for Gotistobart in Phase 3 Squamous NSCLC Trial

TIPRANKS
·
Sep 14

BioNTech SE (BNTX) Gets a Buy from Morgan Stanley

TIPRANKS
·
Sep 14

BioNTech Says Lung Cancer Drug Candidate Prolonged Lives in Trial

Reuters
·
Sep 14

Movement Alert|BioNTech SE Rises 5.04% in Pre-Market Trading, Phase 3 Lung Cancer Trial Shows Statistically Significant Survival Benefit

Market Focus
·
Sep 14

BioNTech's Lung Cancer Drug Nearly Doubles Survival in Late-Stage Trial, Boosting Oncology Pivot

Stock News
·
Sep 14

BioNTech, OncoC4 announce first median overall survival data from PRESERVE-003

TIPRANKS
·
Sep 14